Activist Jana Takes a Swing at Callaway Golf
Shares of Callaway Golf (NYSE: ELY) have traded sharply higher in June after hedge fund Jana Partners disclosed a 9.5% stake and its intention to advocate for …
Why Eldorado Resorts’ Bet on Caesars Entertainment Has Good Odds
On Sunday, Eldorado Resorts (NASDAQ: ERI) and Caesars Entertainment (NASDAQ: CZR) announced that they had come to an agreement under which the regional casino …
Chipotle Tries a New Answer to Its Worker Churn Problem: Team Bonuses
The low unemployment conditions prevailing in the U.S. today have given workers at the bottom of the wage scale some extra leverage. If you don’t like …
Why Semiconductor Shares Are Rallying After Micron’s Latest Move
Micron Technologies (NASDAQ: MU) thinks it has cut through the Gordian knot that is the trade war — sort of. It’s actually more of a workaround. …
Why Mattel’s Failed Merger Talks Could Be a Good Thing
Shares of Mattel (NASDAQ: MAT) have plunged nearly 40% over the past year, hurt most recently by the company’s failed merger talks with privately held …
After Hours: Rite Aid, Pier 1 Both Hit by Poor Q1s
Wednesday’s post-stock market close news was, as in weeks past, dominated by quarterly results figures released late in the afternoon. The stocks of two …
The Guts of An Apple iPhone Show Exactly What Trump Gets Wrong About Trade
This article was written by Jason Dedrick, Professor of Information Studies, Syracuse University, Greg Linden, Research Associate, University of California, …
Exclusive: How 1 Scrappy All-Business Class Airline Carved Out a Niche for Itself
In recent years, Delta Air Lines (NYSE: DAL), American Airlines, and United Continental and their European joint-venture partners have dominated the …
Did Altria Waste $13 Billion on Juul E-Cigs?
Tobacco giant Philip Morris International (NYSE: PM) spent millions of dollars on a marketing application millions of pages long to get its heated tobacco IQOS …
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)
Celgene (NASDAQ: CELG) and Bristol-Myers Squibb (NYSE: BMY) were scheduled to say their official “I dos” in the coming months, but this blended …